ServicenavigationHauptnavigationTrailKarteikarten

Research unit
INNOSUISSE
Project number
47928.1 IP-LS
Project title
BAP5191: First in human trials

Texts for this project
 GermanFrenchItalianEnglish
Short description
Anzeigen
-
-
Anzeigen
Abstract
Anzeigen
-
-
-

Inserted texts


CategoryText
Short description
(German)
BAP5191: First in human trials
Short description
(English)
BAP5191: First in human trials
Abstract
(German)
BAP5191 developed by Bacoba AG will potentially become the next frontline treatment of cutaneous leishmaniasis and benefit millions. We apply for funds to access expertise and infrastructure to plan and conduct a phase I clinical trial.